JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266109

Human C12orf57 (GRCC10) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

C12orf57 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 1 and Insertion of the selection cassette in exon 1.

View Alternative Names

C10_HUMAN, C12orf57, Protein C10

2 Images
Sanger Sequencing - Human C12orf57 (GRCC10) knockout HEK-293T cell line (AB266109)
  • Sanger seq

Unknown

Sanger Sequencing - Human C12orf57 (GRCC10) knockout HEK-293T cell line (AB266109)

Allele-1 : 2 bp deletion in exon 1

Sanger Sequencing - Human C12orf57 (GRCC10) knockout HEK-293T cell line (AB266109)
  • Sanger seq

Unknown

Sanger Sequencing - Human C12orf57 (GRCC10) knockout HEK-293T cell line (AB266109)

Allele-2 : Insertion of the selection cassette in exon 1.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 1 and Insertion of the selection cassette in exon 1

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266109-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266109 Human C12orf57 (GRCC10) knockout HEK-293T cell line", "number":"AB266109-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266109-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266109 Human C12orf57 (GRCC10) knockout HEK-293T cell line", "number":"AB266109-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
C12orf57
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GRCC10 also known as G-protein coupled receptor C10 is a transmembrane receptor with a molecular mass of approximately 50 kDa. This protein is expressed in various tissues including the brain liver and lungs. The receptor functions mechanically by binding to specific ligands initiating intracellular signaling cascades. The activation of GRCC10 influences numerous cell processes resulting in different physiological outcomes depending on tissue type.
Biological function summary

GRCC10 plays a significant role in cell communication and signaling. It functions as part of a larger receptor complex which allows it to effectively transmit signals from the extracellular environment to the cell's interior. This signaling affects numerous biological processes such as cell proliferation differentiation and apoptosis. GRCC10's activity is important for maintaining the balance between these cellular outcomes which is important for normal development and function.

Pathways

GRCC10 participates in important signaling networks such as the MAPK/ERK and PI3K/AKT pathways. These pathways control cell growth survival and metabolism. GRCC10 interacts with proteins like RAF and AKT within these pathways helping to modulate their activity. Through its pathway involvement GRCC10 contributes to the regulation of important biological processes including response to hormones and growth factors.

GRCC10 has been linked to conditions like cancer and neurological disorders. Aberrant expression or malfunction of GRCC10 can lead to disease progression often through its interaction with proteins like p53 in cancer or tau in neurodegenerative diseases. Research continues to explore the therapeutic potential of targeting GRCC10 to modulate its role in these disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com